October, 2022
Cyprumed to presented data on ORAL PROTAC DELIVERY at the Protein Degradation & Targetting Undruggables 2022 conference in Basel, Switzerland, October 11th and 12th
July, 2022
Grant of FFG Funding (Österreichische Forschungsförderung)
January, 2022
Cyprumed GmbH Enters Agreement with Ferring Pharmaceuticals for Development of Oral Drug Delivery Technology for Patient-Centric non-invasive Peptide Therapeutics Read press release online View/Download pdf
September, 2021
Grant of FFG Funding (Österreichische Forschungsförderung)
October, 2020
US Patent granted
September, 2020
ORF (Austrian Broadcasting Corporation) features an article on Cyprumed research activities Grant of FFG Funding (Österreichische Forschungsförderung)
April, 2020
Grant of FFG Funding (Österreichische Forschungsförderung)
July, 2019
Cyprumed establishes new R&D Center in Innsbruck
December, 2018
European Patent granted
June, 2018
Grant of FFG Funding (Österreichische Forschungsförderung)